pharmacopeia

Cerebrovascular Accident

60 drugs47,147 FAERS reportsMedDRA PT
GET
/api/v1/reaction/cerebrovascular-accident
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

DefinitionNLM MeSH D020521

A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)

Source: U.S. National Library of Medicine — MeSH (Stroke)

Drugs reporting Cerebrovascular Accident (60)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

  1. 1Coal Tar19225%
  2. 2Fexinidazole110%
  3. 3Spongia Tosta39.4%
  4. 4Benzphetamine19.1%
  5. 5Meradimate19.1%
  6. 6Aliskiren3986.7%
  7. 7Asiatic Acid16.7%
  8. 8Coumarin106.1%
  9. 9Moexipril46.0%
  10. 10Florbetaben15.9%
  11. 11Rna15.9%
  12. 12Apixaban3,5405.5%
  13. 13Sinusitisinum35.4%
  14. 14Acitretin2535.3%
  15. 15Dabigatran4,0755.2%
  16. 16Dabigatran Etexilate4,0755.2%
  17. 17Migalastat275.1%
  18. 18Lecithin55.1%
  19. 19Nitroprusside195.0%
  20. 20Ranibizumab1,2374.7%
  21. 21Barium Iodate24.7%
  22. 22Testosterone2,3894.6%
  23. 23Andexanet Alfa304.3%
  24. 24Estrone64.1%
  25. 25Potassium Gluconate14.0%
  26. 26Tenecteplase593.9%
  27. 27Pralidoxime13.8%
  28. 28Dipyridamole1483.7%
  29. 29Eflapegrastim13.6%
  30. 30Nisoldipine423.5%
  31. 31Trihexyphenidyl333.5%
  32. 32Ranolazine3563.5%
  33. 33Drospirenone1,7443.4%
  34. 34Benazepril5513.3%
  35. 35Clopidogrel6,7873.3%
  36. 36Levobunolol33.1%
  37. 37Mesylate5,0482.8%
  38. 38Agalsidase Beta2442.7%
  39. 39Rivaroxaban5,5672.7%
  40. 40Donanemab532.6%
  41. 41Danicopan62.6%
  42. 42Idarucizumab342.4%
  43. 43Fesoterodine2532.4%
  44. 44Insulin Detemir9002.3%
  45. 45Esmolol62.3%
  46. 46Nimodipine242.2%
  47. 47Dasiglucagon12.2%
  48. 48Estrogens1,4852.1%
  49. 49Vutrisiran442.1%
  50. 50Paricalcitol2852.0%
  51. 51Tafamidis3132.0%
  52. 52Icodextrin5791.9%
  53. 53Deuruxolitinib11.8%
  54. 54Insulin Lispro2,4501.8%
  55. 55Cangrelor71.8%
  56. 56Calcium Chloride8531.7%
  57. 57Alteplase2461.7%
  58. 58Magnesium Chloride8021.6%
  59. 59Risankizumab1,1751.5%
  60. 60Medroxyprogesterone7711.5%

Related reactions

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

Literature

Recent PubMed references pinned to Stroke as a MeSH major topic. About the reaction term itself — not about any specific drug.

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Search pharmacopeia

Search drugs, classes, and ingredients